Humanized SLE mice (8 weeks old SCID mice engrafted with 1×107 PBMCs/mouse from patients with SLE) were treated with anti-human DNA-like chimeras, which contained a monoclonal antibody against human inhibitory complement receptor type 1. The gene discussed is CR1; the disease is systemic lupus erythematosus.